Onkos Surgical to Acquire Stryker’s Juvenile Tumor System for Pediatric Bone Cancer

We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Onkos Surgical Inc. announced a definitive agreement with Stryker to acquire the Juvenile Tumor System, an expandable prosthetic system for pediatric patients with bone cancer, according to an Onkos Surgical press release.

The Juvenile Tumor System (JTS) provides limb stabilization and growth in pediatric patients with bone cancer, severe arthropathy, trauma, revision, oncology, and malignant disease. According to the release, the JTS system eliminates the need for multiple limb lengthening surgeries, anesthesia or sedation, and reduces the risk of costly limb reconstruction surgery.

“This is an important day for Onkos Surgical and the musculoskeletal oncology community,” Patrick Tracy, co-founder and CEO of Onkos Surgical, said in the statement. “Our ‘why’ has always driven us to specifically address the many clinical challenges this community of surgeons and patients face on a daily basis. Pediatric cancer surgery and limb lengthening are complex and difficult procedures, and the JTS expandable prosthesis is a solution in service of this mission.

Christine E. Phillips